See also this year's filing and all EDGAR filings for this company.
PDF Report 0001739426_2022_RVL_Pharmaceuticals_plc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001739426, RVL Pharmaceuticals plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 59,379,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 83,057,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 2,234,000 |
| 4 | LiabilitiesCurrent | 20,108,000 |
| 5 | LiabilitiesNoncurrent | 592,000 |
| 6 | remainder_Liabilities | 47,237,000 |
| 7 | CostOfGoodsAndServicesSold | 2,386,961 |
| 8 | SellingGeneralAndAdministrativeExpense | 88,737,048 |
| 9 | ResearchAndDevelopmentExpense | 8,636,204 |
| 10 | remainder_Expenses | 11,369,820 |
| 11 | remainder_Revenues | 5,380,041 |
| 12 | remainder_NetIncome | 33,087,459 |
| 13 | remainder_ComprehensiveNetIncome | 6,065,608 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 144,670,000 |
| 1 | Liabilities | 67,937,000 |
| 2 | Expenses | 111,130,033 |
| 3 | Revenues | 5,380,041 |
| 4 | StockholdersEquity | 76,733,000 |
| 5 | NetIncome | -72,662,533 |
| 6 | ComprehensiveNetIncome | -69,629,729 |
| 7 | BaseVar | 184,135,070 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.919 |
| 9 | EconomicCapitalRatio | 2.24 |
Edgar->Model Mapping
Feature Distribution
Change over Time
